Literature DB >> 21505078

Functional significance of mutations in the Snf2 domain of ATRX.

Matthew Mitson1, Lawrence A Kelley, Michael J E Sternberg, Douglas R Higgs, Richard J Gibbons.   

Abstract

ATRX is a member of the Snf2 family of chromatin-remodelling proteins and is mutated in an X-linked mental retardation syndrome associated with alpha-thalassaemia (ATR-X syndrome). We have carried out an analysis of 21 disease-causing mutations within the Snf2 domain of ATRX by quantifying the expression of the ATRX protein and placing all missense mutations in their structural context by homology modelling. While demonstrating the importance of protein dosage to the development of ATR-X syndrome, we also identified three mutations which primarily affect function rather than protein structure. We show that all three of these mutant proteins are defective in translocating along DNA while one mutant, uniquely for a human disease-causing mutation, partially uncouples adenosine triphosphate (ATP) hydrolysis from DNA binding. Our results highlight important mechanistic aspects in the development of ATR-X syndrome and identify crucial functional residues within the Snf2 domain of ATRX. These findings are important for furthering our understanding of how ATP hydrolysis is harnessed as useful work in chromatin remodelling proteins and the wider family of nucleic acid translocating motors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21505078     DOI: 10.1093/hmg/ddr163

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  26 in total

1.  ATRX-mediated chromatin association of histone variant macroH2A1 regulates α-globin expression.

Authors:  Kajan Ratnakumar; Luis F Duarte; Gary LeRoy; Dan Hasson; Daniel Smeets; Chiara Vardabasso; Clemens Bönisch; Tianying Zeng; Bin Xiang; David Y Zhang; Haitao Li; Xiaowo Wang; Sandra B Hake; Lothar Schermelleh; Benjamin A Garcia; Emily Bernstein
Journal:  Genes Dev       Date:  2012-03-01       Impact factor: 11.361

2.  ATRX directs binding of PRC2 to Xist RNA and Polycomb targets.

Authors:  Kavitha Sarma; Catherine Cifuentes-Rojas; Ayla Ergun; Amanda Del Rosario; Yesu Jeon; Forest White; Ruslan Sadreyev; Jeannie T Lee
Journal:  Cell       Date:  2014-11-06       Impact factor: 41.582

Review 3.  Histone methylation: a dynamic mark in health, disease and inheritance.

Authors:  Eric L Greer; Yang Shi
Journal:  Nat Rev Genet       Date:  2012-04-03       Impact factor: 53.242

4.  α-Thalassemia, mental retardation, and myelodysplastic syndrome.

Authors:  Richard J Gibbons
Journal:  Cold Spring Harb Perspect Med       Date:  2012-10-01       Impact factor: 6.915

5.  Single-cell analysis of Daxx and ATRX-dependent transcriptional repression.

Authors:  Alyshia Newhart; Ilona U Rafalska-Metcalf; Tian Yang; Dmitri G Negorev; Susan M Janicki
Journal:  J Cell Sci       Date:  2012-09-12       Impact factor: 5.285

6.  Characterization of the Drosophila group ortholog to the amino-terminus of the alpha-thalassemia and mental retardation X-Linked (ATRX) vertebrate protein.

Authors:  Brenda López-Falcón; Silvia Meyer-Nava; Benjamín Hernández-Rodríguez; Adam Campos; Daniel Montero; Enrique Rudiño; Martha Vázquez; Mario Zurita; Viviana Valadez-Graham
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

7.  A novel missense mutation in ATRX uncovered in a Yemeni family leads to alpha-thalassemia/mental retardation syndrome without alpha-thalassemia.

Authors:  A R Hamzeh; P Nair; M Mohamed; F Saif; N Tawfiq; M T Al-Ali; F Bastaki
Journal:  Ir J Med Sci       Date:  2016-02-09       Impact factor: 1.568

8.  ATRX promotes heterochromatin formation to protect cells from G-quadruplex DNA-mediated stress.

Authors:  Yu-Ching Teng; Aishwarya Sundaresan; Ryan O'Hara; Vincent U Gant; Minhua Li; Sara Martire; Jane N Warshaw; Amrita Basu; Laura A Banaszynski
Journal:  Nat Commun       Date:  2021-06-23       Impact factor: 14.919

9.  ATRX Alteration Contributes to Tumor Growth and Immune Escape in Pleomorphic Sarcomas.

Authors:  Lucie Darmusey; Gaëlle Pérot; Noémie Thébault; Sophie Le Guellec; Nelly Desplat; Laëtitia Gaston; Lucile Delespaul; Tom Lesluyes; Elodie Darbo; Anne Gomez-Brouchet; Elodie Richard; Jessica Baud; Laura Leroy; Jean-Michel Coindre; Jean-Yves Blay; Frédéric Chibon
Journal:  Cancers (Basel)       Date:  2021-04-29       Impact factor: 6.639

10.  Molecular Features of Cancers Exhibiting Exceptional Responses to Treatment.

Authors:  David A Wheeler; Naoko Takebe; Toshinori Hinoue; Katherine A Hoadley; Maria F Cardenas; Alina M Hamilton; Peter W Laird; Linghua Wang; Adrienne Johnson; Ninad Dewal; Vincent Miller; David Piñeyro; Manuel Castro de Moura; Manel Esteller; Hui Shen; Jean Claude Zenklusen; Roy Tarnuzzer; Lisa M McShane; James V Tricoli; Paul M Williams; Irina Lubensky; Geraldine O'Sullivan-Coyne; Elise C Kohn; Richard F Little; Jeffrey White; Shakun Malik; Lyndsay Harris; Carol Weil; Alice P Chen; Chris Karlovich; Brian Rodgers; Lalitha Shankar; Paula Jacobs; Tracy Nolan; Jianhong Hu; Donna M Muzny; Harshavardhan Doddapaneni; Viktoriya Korchina; Julie Gastier-Foster; Jay Bowen; Kristen Leraas; Elijah F Edmondson; James H Doroshow; Barbara A Conley; S Percy Ivy; Louis M Staudt
Journal:  Cancer Cell       Date:  2020-11-19       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.